Alpha cyclodextrin

DRUG2 trials

Sponsors

National Heart, Lung, and Blood Institute (NHLBI), Evgen Pharma

Conditions

Cardiovascular DiseaseStage, Prostate Cancer

Phase 1

Sulforadex in Healthy Volunteers SAD

CompletedNCT01948362

Evgen PharmaStage, Prostate Cancer

Start: 2012-11-30End: 2013-02-28Updated: 2013-09-23

Phase 2

Evaluation of Oral Alpha-Cyclodextrin for Decreasing Serum Cholesterol

CompletedNCT01131299

National Heart, Lung, and Blood Institute (NHLBI)Cardiovascular Disease

Start: 2010-03-31End: 2015-02-28Updated: 2016-10-21

Related Papers

A Randomised Controlled Trial of SFX-01 After Subarachnoid Haemorrhage — The SAS Study

Translational Stroke Research2024-07-196 citations

Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial

BMJ Open2020-03-0133 citations

Randomized double blind clinical trial on the effect of oral α-cyclodextrin on serum lipids.

2016-07-1231 citations